Tag Archives: Financial
Results of Operations and Financial Condition, Regulation FD Disclos – Yahoo! Finance
The Company believes these expansions will enable it to further broaden physician awareness of Acthar and its appropriate role in the treatment of Nephrotic Syndrome, MS relapses and the rheumatology conditions dermatomyositis and polymyositis. Insurance … Bing News – Full … Continue reading
BioMarin Announces First Quarter 2012 Financial Results – msnbc.com
3Q 2012: Results for Phase II trial for PEG-PAL for PKU 3Q 2012: Results for Phase I trial for BMN-111 for achondroplasia in healthy volunteers 2H 2012: Results for Phase I/II trial for BMN-673 for solid tumors 4Q 2012: Results … Continue reading
Threshold Pharmaceuticals Reports Fourth Quarter and Year End 2011 Financial and Operational Results – Yahoo Finance
The “410 trial” is a Phase 1/2 trial in combination with sunitinib in patients with renal cell carcinoma, gastrointestinal stromal tumors or pancreatic neuroendocrine tumors. To date, across all clinical trials, TH-302 has been administered to … Bing News – … Continue reading
NPS Pharmaceuticals Reports 2011 Year-End Financial Results and 2012 Cash Burn Guidance – Yahoo Finance
Natpara™ (recombinant human parathyroid hormone [1-84]) in hypoparathyroidism In November 2011, NPS reported that its 28-week, double-blind, placebo-controlled, Phase 3 registration study of Natpara, known as REPLACE, met its primary efficacy … Bing News – Full Story →
BIOTRONIK Introduces the World’s First and Only Implantable Defibrillators Eligible for Magnetic Resonance Imaging – Financial Post
After receiving CE approval on November 18th, the first device implantations were performed at a number of hospitals in several European countries. Santini continued, “The ability to use MR scans is extremely important and will become even … Bing News … Continue reading
Power: Local utilities will do the lion’s share – Financial Times
Many people have an image of central Europe as a place of coal-fired factories belching smoke. However, an enormous wave of investment is likely to transform that picture, as the region moves away from coal-generated electricity to a mix based … Continue reading
XenoPort Reports Second Quarter Financial Results – Marketwatch
XenoPort initiated a pivotal Phase 3 clinical trial of arbaclofen placarbil (AP) as a potential treatment of spasticity in multiple sclerosis (MS) patients. Assuming positive results, the pivotal trial, which is being conducted under a Special Protocol … Bing News … Continue reading
The pain at the heart of the matter – Financial Times
The accompanying text was clear: “A chest pain is your body saying call 999”. Heart attacks are a leading cause of death in the UK, but many people still delay seeing the doctor for a chest pain, believing a myocardial … Continue reading
Cyclacel Pharmaceuticals to Announce Year End & Fourth Quarter 2010 Financial Results and Presentation at Upcoming Conference – msnbc.com
and in Phase 2 studies for myelodysplastic syndromes and lung cancer. Seliciclib (CYC202 or R-roscovitine), a CDK (cyclin dependent kinase) inhibitor, is in Phase 2 studies for the treatment of lung cancer and nasopharyngeal cancer and in a Phase 1 trial … Continue reading
YM BioSciences Releases 2Q Fiscal 2011 Operational and Financial Results – TradingMarkets.com
In addition to demonstrating positive efficacy signals in the approvable endpoints in this indication, splenomegaly and symptomatic improvement, CYT387 also exhibited a promising ability to positively impact anemia, a major life-shortening symptom … Bing News – Full Story →
